Applying FRESCO Trial Insights in Real-World Management of mCRC

Sponsored by Takeda Oncology Please see Important Safety Information and Full Prescribing Information. INDICATION FRUZAQLA® (fruquintinib) is indicated for the treatment of adult patients with metastatic […]